Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2012
08/08/2012CN101804032B Preparation method of 5-fluorouracil-wrapped biodegradable polylactic acid/nano-hydroxyapatite compound microspheres
08/08/2012CN101803531B China cryptoporus sinensis and solid cultural method and application thereof
08/08/2012CN101724010B Preparation method and application of tumor tissue complete antigen
08/08/2012CN101679310B Alkynylpyrimidines as Tie2 kinase inhibitors
08/08/2012CN101611055B Human antibodies to human DELTA like ligand 4
08/08/2012CN101590193B Traditional Chinese medicine combination for treating leukemia and preparation method thereof
08/08/2012CN101590091B Traditional Chinese medicine combination for treating leukemia and preparation method thereof
08/08/2012CN101543298B Rutin chewing agent and method for preparing same
08/08/2012CN101506183B Human protein tyrosine phosphatase inhibitors and methods of use
08/08/2012CN101497568B Use of Sichuang-Tibet amethystoidin A in preventing and treating acute lymphocyte leukaemia and cervical cancer
08/08/2012CN101490052B Therapeutic compounds and their use in cancer
08/08/2012CN101489547B Macrocyclic kinase inhibitors
08/08/2012CN101485791B Application of Ampelopsis grossedentata total flavone in preparing medicament for preventing and treating adverse reaction of tumor chemoradiotherapy
08/08/2012CN101434631B Estra nitrate ester medicament for inhibiting angiogenesis
08/08/2012CN101351201B Pharmaceutical preparation of aqueous solution containing platinum complex
08/08/2012CN101195822B High-endophilicity targeting amalgamation protein
08/08/2012CN101151371B Retrotransposon inhibition in therapy
08/08/2012CN101148642B Probiotic/non-probiotic combinations
08/08/2012CN101092636B Selectively replicating viral vectors, preparation method and application
08/08/2012CN101074202B Production of injecting reductive glutathione
08/08/2012CN101027070B Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
08/07/2012US8236965 Benzimidazole derivatives and their use as a medicament
08/07/2012US8236951 Thioxanthine derivatives as myeloperoxidase inhibitors
08/07/2012US8236809 Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activation
08/07/2012US8236798 Carboxamide compounds and their use as calpain inhibitors
08/07/2012US8236794 Antitumor agents; using taurolidine; administering into lungs
08/07/2012US8236774 Human telomerase catalytic subunit
08/07/2012US8236541 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
08/07/2012US8236510 Protein showing enhanced expression in cancer cells
08/07/2012US8236507 Modulators of TNF receptor associated factor (TRAF), their preparation and use
08/07/2012US8236487 Tumor specific oligosaccharide sequences and use thereof
08/07/2012US8236339 Therapeutic delivery of carbon monoxide
08/07/2012CA2656915C Human protein tyrosine phosphatase inhibitors and methods of use
08/07/2012CA2606861C Stable nanoparticle formulations
08/07/2012CA2565213C Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms
08/07/2012CA2514992C Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
08/07/2012CA2477737C Multi-substituted selective androgen receptor modulators and methods of use thereof
08/07/2012CA2457652C Soluble t cell receptor
08/07/2012CA2450087C Benzisoselenazolonyl derivatives having antineoplastic, anti-inflammatory and antithrombotic activities as well as their use
08/07/2012CA2447367C Diagnosis and treatment of malignant neoplasms
08/07/2012CA2438314C 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
08/07/2012CA2402213C Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant
08/07/2012CA2319715C Breast cancer resistance protein (bcrp) and the dna which encodes it
08/07/2012CA2317721C Novel steroid-activated nuclear receptors and uses therefor
08/07/2012CA2309676C Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
08/07/2012CA2146895C Ctla4/cd28ig hybrid fusion proteins
08/02/2012WO2012103457A2 Stilbene analogs and methods of treating cancer
08/02/2012WO2012103456A2 Polycyclic beta lactam derivatives for the treatment of cancer
08/02/2012WO2012103226A2 Bendamustine formulations
08/02/2012WO2012103165A2 Anti-kit antibodies and uses thereof
08/02/2012WO2012103163A2 Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathy
08/02/2012WO2012103059A2 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
08/02/2012WO2012102937A2 Compounds that expand hematopoietic stem cells
08/02/2012WO2012102527A2 Novel use of regulatory t cell-specific surface protein lrig-1
08/02/2012WO2012102521A2 Human anti-cd23 fab antibody and a pharmaceutical composition for treating tumours comprising same
08/02/2012WO2012102363A1 Drug delivery system and use of same
08/02/2012WO2012101564A2 Anti-inflammatory compounds
08/02/2012WO2012101239A1 Derivatives of azaindazole or diazaindazole type as medicament
08/02/2012WO2012101238A1 New pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors
08/02/2012WO2012101186A1 New 5-alkynyl-pyridines
08/02/2012WO2012101184A1 New 5-alkynyl-pyridines
08/02/2012WO2012101109A1 Native dendritic cells
08/02/2012WO2012101066A1 Pyridine biaryl amine compounds and their uses
08/02/2012WO2012101064A1 N-acyl pyrimidine biaryl compounds as protein kinase inhibitors
08/02/2012WO2012101063A1 N-acyl pyridine biaryl compounds and their uses
08/02/2012WO2012101062A1 Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
08/02/2012WO2012101032A1 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
08/02/2012WO2012101029A1 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
08/02/2012WO2012100957A1 Inhibitors of branched-chain-aminotransferase-1 (bcat1) for the treatment of brain tumors
08/02/2012WO2012100723A1 Use of artemisinin b in preparation of antitumor drug
08/02/2012WO2012100654A1 Ribofuranosyl purine compound, preparation method therefor, and use thereof
08/02/2012WO2012100590A1 Liposome comprising combination of chloroquine and adriamycin and preparation method thereof
08/02/2012WO2012100573A1 New molecular marker cuedc2 protein for prognostic determination of breast cancer endocrinology therapy
08/02/2012WO2012100459A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
08/02/2012WO2012100436A1 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
08/02/2012WO2012100389A1 Triterpenoid saponin compounds, preparation methods and uses thereof
08/02/2012WO2012100384A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof
08/02/2012WO2012100368A1 Method for screening tumor cells and use thereof.
08/02/2012WO2012100346A1 Antibodies selective for cells presenting egfr at high density
08/02/2012WO2012078757A3 Combination for breast cancer therapy with hsp90 inhibitory compounds
08/02/2012WO2012075362A3 Chemokine cxcr4 receptor modulators and used related thereto
08/02/2012WO2012075241A3 Protease degradable polypeptides and uses thereof
08/02/2012WO2012071269A3 Selective removal of cells having accumulated agents
08/02/2012WO2012065156A3 Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells
08/02/2012WO2012064146A9 Anticancer composition containing gkn 1
08/02/2012WO2012061418A3 Benzamides and nicotinamides as syk modulators
08/02/2012WO2012053741A9 Nucleic acid molecules inducing rna interference, and uses thereof
08/02/2012WO2012051296A3 Purine-based triazoles
08/02/2012WO2012030914A8 4-azolylaminoquinazoline derivatives and methods of use thereof
08/02/2012WO2012006145A3 Com positions and methods for retargeting virus constructs
08/02/2012WO2012003287A3 Compositions and methods for detecting and quantifying circulating tumor cells ctcs
08/02/2012US20120197060 Radiation enhanced macromolecular delivery of therapeutic agents for chemotherapy technology
08/02/2012US20120197059 Ubiquitin interacting motif peptides as cancer therapeutics
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120196936 Composition Comprising S-Allyl-L-Cysteine as Active Ingredient for Preventing or Treating Gastrointestinal Disorders
08/02/2012US20120196925 Therapeutic and Diagnostic Molecules
08/02/2012US20120196922 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency
08/02/2012US20120196916 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
08/02/2012US20120196915 Antitumor 1,2-Diphenylpyrrole Compounds and their Preparation Process
08/02/2012US20120196907 Diazonamide Analogs
1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 2211